We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$425M
AUM Growth
-$15.1M
Cap. Flow
-$16.3M
Cap. Flow %
-3.83%
Top 10 Hldgs %
62.8%
Holding
245
New
62
Increased
20
Reduced
25
Closed
131

Sector Composition

Rank Sector Weight
1 Communication Services 27.02%
2 Technology 20.72%
3 Consumer Staples 6.78%
4 Materials 5.87%
5 Financials 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRE icon
76
CBRE Group
CBRE
$40.8B
$380K 0.09%
8,043
+2,169
+37% +$98.8K
APO icon
77
Apollo Global Management
APO
$70.7B
$366K 0.09%
+12,343
New +$415K
PTC icon
78
PTC
PTC
$13.7B
$346K 0.08%
+4,429
New +$323K
H icon
79
Hyatt Hotels
H
$17.6B
$303K 0.07%
+3,972
New +$312K
YPF icon
80
YPF
YPF
$20.2B
$262K 0.06%
+12,137
New +$281K
OEF icon
81
iShares S&P 100 ETF
OEF
$19.8B
$237K 0.06%
+2,046
New +$248K
BURL icon
82
Burlington
BURL
$22B
$228K 0.05%
+1,715
New +$212K
WCG
83
DELISTED
Wellcare Health Plans, Inc.
WCG
$216K 0.05%
+1,114
New +$223K
ARWR icon
84
Arrowhead Research
ARWR
$12.1B
$210K 0.05%
29,080
-18,603
-39% -$115K
AA icon
85
Alcoa
AA
$11.7B
$208K 0.05%
+4,633
New +$229K
JLL icon
86
Jones Lang LaSalle
JLL
$15.1B
$203K 0.05%
+1,162
New +$187K
DUC
87
DELISTED
Duff & Phelps Utility & Corporate Bond Trust
DUC
$196K 0.05%
+22,805
New +$199K
CBAY
88
DELISTED
Cymabay Therapeutics
CBAY
$194K 0.05%
14,933
-18,864
-56% -$234K
VKTX icon
89
Viking Therapeutics
VKTX
$4.04B
$175K 0.04%
40,000
WG
90
DELISTED
Willbros Group
WG
$159K 0.04%
+287,817
New +$287K
JHA
91
DELISTED
Nuveen High Inc Dec 2018 Tgt Trm
JHA
$156K 0.04%
15,930
-14,001
-47% -$138K
PVLA
92
Palvella Therapeutics
PVLA
$1.98B
$136K 0.03%
+250
New +$155K
VCEL icon
93
Vericel Corp
VCEL
$2.3B
$125K 0.03%
12,525
-13,349
-52% -$110K
DERM
94
DELISTED
Dermira, Inc.
DERM
$100K 0.02%
+12,500
New +$272K
PHT
95
DELISTED
Pioneer High Income Fund
PHT
$98K 0.02%
10,462
-21,070
-67% -$202K
SRNE
96
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$98K 0.02%
19,018
-18,864
-50% -$134K
XXII
97
22nd Century Group
XXII
$1.47M
0
ENPH icon
98
Enphase Energy
ENPH
$4.84B
$96K 0.02%
21,062
-33,760
-62% -$103K
KDMN
99
DELISTED
Kadmon Holdings, Inc.
KDMN
$83K 0.02%
19,440
-32,290
-62% -$138K
DHF
100
BNY Mellon High Yield Strategies Fund
DHF
$171M
$82K 0.02%
25,652
-8,214
-24% -$26.7K

Similar funds

Alpine Global Management's Q1 2018 Portfolio in Review

As of Q1 2018, Alpine Global Management held 245 positions worth $425M, down 3.4% from $440M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Alpine Global Management withdrew a net $16.3M in Q1 2018, closing 131 positions and reducing 25 holdings. Its most notable exit was CR Bard Inc., an estimated $39.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 27% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Alpine Global Management opened a new position in Keurig Dr Pepper worth $26.9M.

  • Alpine Global Management's largest Q1 2018 buy was Keurig Dr Pepper: 227,075 shares worth $26.9M.
  • Alpine Global Management added most to NXP Semiconductors in Q1 2018, an estimated $27.5M increase.
  • Alpine Global Management's biggest Q1 2018 reduction was Unilever, cutting an estimated $3.67M.
  • Alpine Global Management fully exited CR Bard Inc. in Q1 2018, selling an estimated $39.3M.
  • Alpine Global Management's ten largest holdings make up 63% of its $425M portfolio in Q1 2018.
  • Alpine Global Management opened 62 new positions and closed 131 in Q1 2018.
  • Alpine Global Management's portfolio value fell 3.4% quarter-over-quarter to $425M.

Based on Alpine Global Management's 13F filing for Q1 2018, filed 16 May 2018.